Regeneron Pharmaceuticals, Inc.REGNNASDAQ
Loading
Operating Cash Flow Growth Recovery in ProgressRecovering
Percentile Rank57
5Y CAGR+10.3%
Year-over-Year Change
Year-over-year operating cash flow growth rate
5Y CAGR
+10.3%/yr
Long-term compound
Percentile
P57
Within normal range
vs 5Y Ago
1.6x
Solid growth
Streak
3 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | 12.63% |
| 2024 | -3.78% |
| 2023 | -8.39% |
| 2022 | -29.18% |
| 2021 | 170.47% |
| 2020 | 7.74% |
| 2019 | 10.70% |
| 2018 | 67.94% |
| 2017 | -12.03% |
| 2016 | 11.66% |